For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the arrival of Tafamidis and Tafamidis meglumine represents a true change. These novel therapies preserve the transthyretin protein, halting its destructive build-up and alleviating the burden of the get more info illness. Individuals are now reporting imp